search
Back to results

Noninvasive Blood Pressure Monitor Evaluation Including Performance During Dysrhythmias

Primary Purpose

Healthy

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Non invasive blood pressure monitor
Sponsored by
GE Healthcare
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Healthy focused on measuring Non-Invasive Blood Pressure, Sinus Rhythm, Oscillometric, Invasive Blood Pressure, AAMI/ANSI SP10 Standard, Compliance with ANSI/AAMI SP10 2002 standard

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • signed informed consent
  • a patient who is undergoing a specialized procedure such as a surgical procedure or cardiac catheterization, or during critical care monitoring in which a central arterial catheter is in place to determine systolic, diastolic, and/or mean arterial blood pressure values.
  • ability to monitor ECG, NIBP and/or pulse oximetry
  • presence of atrial fibrillation, atrial flutter, or normal sinus rhythm

Exclusion Criteria:

  • any subject deemed too unstable, at the clinician's discretion, to participate in the study
  • any subject with a cardiac or vascular malformation that results in an abnormal waveform inappropriate to be considered a reference standard
  • any subject with a cardiac anomaly that would cause a disparity between aortic pressures and the periphery.
  • presence of peripheral vascular disease in arms
  • inability to perform a minimum of 4 fast flushes (two at the study beginning and two at the study end) on an arterial catheter or line in order to determine a frequency response. The volume of fluid will not exceed a total pre-specified by the Principal Investigator or designee.
  • if the baseline arm to arm mean difference is > 10 mmHg, then the differences will be recorded and evaluated by the Principal Investigator for possible subject exclusion from the data analysis.
  • subjects who, at the clinician's discretion, could not tolerate approximately 5 to 12, but possibly up to 25 repeated blood pressures on each arm

Sites / Locations

  • GE Healthcare

Outcomes

Primary Outcome Measures

Comparison of early systolic, systolic, and diastolic blood pressure, MAP and pulse rate as collected by an investigational non-invasive blood pressure device versus reference standards

Secondary Outcome Measures

Full Information

First Posted
March 2, 2007
Last Updated
July 25, 2022
Sponsor
GE Healthcare
search

1. Study Identification

Unique Protocol Identification Number
NCT00443001
Brief Title
Noninvasive Blood Pressure Monitor Evaluation Including Performance During Dysrhythmias
Official Title
Noninvasive Blood Pressure Monitor Evaluation Including Performance During Dysrhythmias
Study Type
Interventional

2. Study Status

Record Verification Date
July 2022
Overall Recruitment Status
Completed
Study Start Date
April 2007 (undefined)
Primary Completion Date
July 2007 (Actual)
Study Completion Date
July 2007 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
GE Healthcare

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This protocol focuses on the evaluation of the GE noninvasive blood pressure parameter in subjects with dysrhythmias and normal sinus rhythm. The study follows the recommendations of the ANSI/AAMI SP10 Standard.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Healthy
Keywords
Non-Invasive Blood Pressure, Sinus Rhythm, Oscillometric, Invasive Blood Pressure, AAMI/ANSI SP10 Standard, Compliance with ANSI/AAMI SP10 2002 standard

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
Non invasive blood pressure monitor
Intervention Description
Updated device and software to improve performance in patients with dysrhythmia
Primary Outcome Measure Information:
Title
Comparison of early systolic, systolic, and diastolic blood pressure, MAP and pulse rate as collected by an investigational non-invasive blood pressure device versus reference standards
Time Frame
1-4 hours

10. Eligibility

Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: signed informed consent a patient who is undergoing a specialized procedure such as a surgical procedure or cardiac catheterization, or during critical care monitoring in which a central arterial catheter is in place to determine systolic, diastolic, and/or mean arterial blood pressure values. ability to monitor ECG, NIBP and/or pulse oximetry presence of atrial fibrillation, atrial flutter, or normal sinus rhythm Exclusion Criteria: any subject deemed too unstable, at the clinician's discretion, to participate in the study any subject with a cardiac or vascular malformation that results in an abnormal waveform inappropriate to be considered a reference standard any subject with a cardiac anomaly that would cause a disparity between aortic pressures and the periphery. presence of peripheral vascular disease in arms inability to perform a minimum of 4 fast flushes (two at the study beginning and two at the study end) on an arterial catheter or line in order to determine a frequency response. The volume of fluid will not exceed a total pre-specified by the Principal Investigator or designee. if the baseline arm to arm mean difference is > 10 mmHg, then the differences will be recorded and evaluated by the Principal Investigator for possible subject exclusion from the data analysis. subjects who, at the clinician's discretion, could not tolerate approximately 5 to 12, but possibly up to 25 repeated blood pressures on each arm
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Russel Hirsch, MD
Organizational Affiliation
Cardiac Catheterization Laboratory Division of Cardiology
Official's Role
Study Director
Facility Information:
Facility Name
GE Healthcare
City
Milwaukee
State/Province
Wisconsin
ZIP/Postal Code
53223
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Noninvasive Blood Pressure Monitor Evaluation Including Performance During Dysrhythmias

We'll reach out to this number within 24 hrs